Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.

被引：0
|
作者：
Wong, JB [1 ]
机构：
[1] Tufts New England Med Ctr, Boston, MA USA
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1062
引用
下载
收藏
页码：425A / 425A
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of ribavirin and pegylated interferon alfa-2b for initial treatment of chronic hepatitis C.
    Wong, JB
    Siebert, U
    Manns, MP
    McHutchison, JG
    Sroczynski, G
    Wasem, J
    Ravens-Sieberer, U
    Rossol, S
    Ling, MH
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 691A - 691A
  • [2] Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.
    Wong, JB
    Davis, GL
    Pauker, SG
    HEPATOLOGY, 1998, 28 (04) : 591A - 591A
  • [3] Cost-effectiveness of initial ribavirin interferon alfa-2B for chronic hepatitis C
    Wong, J
    McHutchinson, JG
    Poynard, T
    Ling, MH
    Albrecht, HK
    Pauker, SD
    GASTROENTEROLOGY, 1999, 116 (04) : A1289 - A1289
  • [4] Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden
    Sennfält, K
    Reichard, O
    Hultkrantz, R
    Wong, JB
    Jonsson, D
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (08) : 870 - 876
  • [5] The cost-effectiveness analysis of peginterferon alfa-2a and ribavirin versus interferon alfa-2b and ribavirin in chronic hepatitis C in Poland
    Orlewska, E
    Juszczyk, J
    VALUE IN HEALTH, 2003, 6 (06) : 749 - 750
  • [6] Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
    Wong, JB
    Davis, GL
    Pauker, SG
    AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 366 - 373
  • [7] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [8] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [9] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [10] Impact of optimized treatment algorithms on the cost-effectiveness of ribavirin and peginterferon alfa-2B for chronic hepatitis C.
    Wong, JB
    McHutchison, JG
    Manns, MP
    Davis, GL
    Albrecht, JK
    HEPATOLOGY, 2002, 36 (04) : 717A - 717A
12345